Periodontal Treatment Lowers HbA1c | 医療法人社団EPSDC

An Unexpected Key to Glycemic Control Is in the Mouth — Evidence That Periodontal Treatment Lowers HbA1c (Dr. Hiroshi Miyashita)

Experience
I am Hiroshi Miyashita, Director of Tokyo International Dental Roppongi. For many years I have specialized in periodontal and endodontic care and have treated numerous patients with diabetes, coordinating periodontal therapy with their systemic management. In clinical practice I have observed cases where periodontal treatment was followed by improved glycemic control, and I recognize the clinical significance of this relationship.

Expertise

I have practical expertise in periodontal disease pathophysiology, non‑surgical therapies such as scaling and root planing (SRP), and post‑treatment maintenance.
I am familiar with the physiological mechanisms by which periodontal inflammation raises systemic inflammatory markers (e.g., CRP) and worsens insulin resistance, based on up‑to‑date literature.
I incorporate findings from systematic reviews, including the 2022 Cochrane update and analyses of 35 studies with 3,249 participants, into clinical decision‑making.

Authority

Our clinic applies protocols that prioritize collaboration between dentistry and medicine, grounded in internationally trusted systematic review evidence.
I have experience integrating interdisciplinary research and guideline findings into everyday practice and collaborating with medical clinics that manage diabetes.

Trustworthiness

At our clinic we develop safe periodontal treatment plans individualized to each patient’s systemic status (HbA1c, medications, comorbidities) and coordinate care with their physician. Explanations are always evidence‑based; I communicate expected benefits and limitations clearly and honestly.

Main points and clinical implications

Evidence summary — what the data show
Meta‑analyses and recent systematic reviews indicate that professional periodontal therapy (primarily SRP) in patients with diabetes is associated with an average HbA1c reduction of approximately 0.43% at 3–4 months. Some studies report sustained reductions of ~0.30% at 6 months and ~0.50% at 12 months. Clinically, this effect size is comparable to adding one hypoglycemic medication in many treatment scenarios.

Why periodontal treatment can lower blood glucose (mechanism)
Periodontitis produces chronic oral inflammation; the ulcerated periodontal pocket surface area can be roughly equivalent to the size of a palm, representing a persistent inflammatory burden. Inflammatory cytokines released into the bloodstream promote insulin resistance. Reducing periodontal inflammation lowers markers such as CRP and can improve insulin sensitivity, which is reflected in improved glycemic indices.

Clinical significance — why this matters
Epidemiologic data (e.g., UKPDS) show that each 1% absolute reduction in HbA1c substantially reduces the risk of microvascular complications (retinopathy, nephropathy). A 0.3–0.5% HbA1c decrease from periodontal therapy may therefore contribute meaningfully to complication risk reduction and future healthcare cost savings, supporting integrated medical–dental interventions.

Practical recommendations — what patients can do now

Coordinate with your physician: patients with diabetes should share their HbA1c and medication status when visiting the dental clinic.
Consider professional periodontal therapy: SRP performed by dental hygienists/dentists and targeted plaque control, with surgical treatment as necessary, can reduce systemic inflammatory burden.
Strengthen daily care: maintain correct brushing technique, use floss/interdental brushes, and manage snacking and sugar intake.
Maintain follow‑up: regular maintenance every 3–4 months helps prevent recurrence of periodontal inflammation.

Limitations and cautions (realities of the evidence)

Not all patients will experience the same degree of improvement. Response varies with individual factors including diabetes severity, smoking, and obesity.
Periodontal therapy is an adjunct, not a substitute for medical therapy; it complements medication, diet, and exercise.
Some studies show heterogeneity in durability of effect; larger, high‑quality trials are still needed.

Conclusion — a message from the director
One important key to diabetes management may be in your mouth. Professional periodontal therapy has the potential to improve HbA1c, reduce complication risk, and lower future healthcare costs. I strongly recommend incorporating dental assessment and periodontal care into your overall diabetes management plan alongside medications and lifestyle measures. Before your next medical appointment, consider having your oral condition evaluated at our clinic — we are ready to support your systemic health from a dental perspective.

Learn more?

Make an appointment for consultation today.

Tokyo International Dental Clinic Roppongi

Here is the MAP